-
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localized prostate cancer show 100% biochemical free recurrence rate more than two years post-surgery
04 May 2024 09:01 GMT
… patients with high-risk localized prostate cancer (HRLPC) experience disease recurrence within …
-
Plant-Based Diet May Slow Prostate Cancer Progression
04 May 2024 04:21 GMT
… significantly lower the chances of prostate cancer spreading.
The study, published this … may be associated with better prostate cancer–specific outcomes, adding to a …
Plant-Based Diet May Keep Prostate Cancer Under Control
The investigation involved …
-
18F-PSMA-1007 PET/CT Improves Staging Vs MRI in Prostate Cancer
03 May 2024 21:06 GMT
… for the locoregional staging of prostate cancer compared with multiparametric MRI, according … the primary locoregional staging of prostate cancer.
The phase 2 trial was … was the correct identification of prostate cancer in the T stage. Secondary …
-
HIFU Yields Noninferior Outcomes Vs Prostatectomy in Local Prostate Cancer
03 May 2024 21:06 GMT
… in patients with localized prostate cancer, according to findings … = .0001).
The median prostate-specific antigen (PSA) nadir …
Following treatment, the International Prostate Symptom Score was 4 ( … curative treatment of localized prostate cancer GG 1 & …
-
Expert: The Role of Pharmacists in Optimizing Prostate Cancer Care
03 May 2024 17:24 GMT
… the evolving treatment landscape for prostate cancer and the role that pharmacists … considerations for novel medications in prostate cancer?
Scott Soefje: Now these drugs … patients about novel medications for prostate cancer?
Scott Soefje: Pharmacists are an …
-
Metastatic prostate cancer research: PSMAfore follow-on study favors radioligand therapy over change to androgen receptor pathway inhibition
03 May 2024 17:13 GMT
… patients with metastatic castration-resistant prostate cancer by pre-randomization ARPI … patients with metastatic castration-resistant prostate cancer by pre-randomization ARPI … PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) who had …
-
Angle signs AstraZeneca deal to develop prostate cancer assay
03 May 2024 17:06 GMT
… assay for use in prostate cancer studies.
Angle’s Parsotix … assessing the efficacy of prostate cancer therapeutics.
The pair up … annual mortality due to prostate cancer is projected to account … prevalent as lung cancer or colorectal cancer, the forecasted …
-
GLP-1 Agonists May One Day Treat Prostate Cancer
03 May 2024 16:56 GMT
… expression with basal prostate cancer, a rare type of prostate cancer that can present … growth hormones. Patients with prostate cancer and metabolic syndrome have shorter … castrate-resistant prostate cancer (mCRPC), a very late stage of prostate cancer.
In …
-
Plant-Based Diets Slow Progression Of Prostate Cancer, Study Suggests
03 May 2024 16:10 GMT
… plant-based diets may improve prostate cancer outcomes,” the researchers said, … on preventing cancer progression.
Prostate cancer is the third most common cancer in men … and the risk of prostate cancer development and prostate cancer mortality has been well …
-
Lionel Richie Just Gave an Positive Update on King Charles' Cancer: 'He Is Doing Fantastic'
04 May 2024 00:46 GMT
… ’ health following his cancer diagnosis have been sporadic … cancer diagnosis in February, following a “corrective procedure” for an enlarged prostate … who are affected by cancer.”
Charles’ return … University College Hospital Macmillan Cancer Centre. The couple …